Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Orbus names co-founder, COO Levin president

Plus: Michael Bell becomes CTO of Chemify, and updates from Genbio AI and Epivax

March 1, 2025 1:56 AM UTC

Bob Myers, co-founder, president and CEO of  Orbus Therapeutics Inc. for more than a decade, will step down from the role as a day-to-day executive to pursue other opportunities in industry. Myers’ fellow co-founder and COO Jason Levin will become president of the rare disease company.

Scotland-based drug discovery company Chemify Ltd. hired Michael Bell as CTO. Bell was SVP of digital at Lucid Motors and has previously held roles for 15 years at Apple. Chemify is using its AI platform to design molecules...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article